Efficacy of the mode of delivery of autologous bone marrow cells into heart scar muscle for the recovery of contractile function

ISRCTN ISRCTN47591706
DOI https://doi.org/10.1186/ISRCTN47591706
Protocol serial number N0523154398
Sponsor Department of Health
Funder Good Hope Hospital NHS Trust (UK)
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
05/04/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Francisco Leyva
Scientific

Consultant Cardiologist
Good Hope Hospital NHS Trust
Rectory Road
Sutton Coldfield
Birmingham
B75 7RR
United Kingdom

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific title
Study objectivesStudy the efficacy of the intravascular as compared to intramuscular administration of autologous bone marrow in the reduction of scar tissue in the heart muscle and in the improvement of segmental contactile function
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSurgery: Coronary artery bypass grafting (CABG)
Intervention[A] Control group receiving only myocardial revascularisation
[B] Direct injection into the scar muscle of self bone marrow mononuclear cells in addition to myocardial revascularisation
[C] Intravascular administration of self bone marrow into the graft used for myocardial revascularisation
Intervention typeProcedure/Surgery
Primary outcome measure(s)

Functional improvement, and reduction in size of scar areas. The study will also establish whether the number and the type of transplanted bone marrow mononuclear cells is correlated with the recovery of contractile function by performing multiple linear regression analysis.

Key secondary outcome measure(s)

Not provided at time of registration

Completion date07/04/2007

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit80 Years
SexNot Specified
Target sample size at registration90
Key inclusion criteriaPatients undergoing coronary bypass graft surgery aged between 18 and 80. Estimated 30 patients per group in order to detect significance
Key exclusion criteriaNot provided at time of registration
Date of first enrolment07/04/2004
Date of final enrolment07/04/2007

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

Consultant Cardiologist
Birmingham
B75 7RR
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/10/2008 Yes No